The personalised medicine technology provider hiked its overall funding to $115m, with Cardinal Health, McKesson Ventures and Novartis all backing a series C extension.
Healthcare services provider Cardinal Health led the $33m second tranche of a series C round for Vineti, the US-based operator of a personalised medicine management product, on Tuesday that now totals $68m.
McKesson Ventures, the investment arm of pharmaceutical distributor McKesson, also took part in the round, as did pharmaceutical firm Novartis, Canaan Partners, Threshold Ventures, Section 32, Casdin Capital, LifeForce Capital, Marc Benioff and undisclosed other investors.
Formerly known as Vitruvian Networks, Vineti has built a cloud…
